Dongxin Pharmaceutical

Dongxin Pharmaceutical, primarily operating as Wuhan Dongxin Pharmaceutical Co., Ltd., is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of dermatological, gynecological, and respiratory treatments. Headquartered in Wuhan, the company is particularly recognized for its market leadership in external-use medications, including a wide array of creams, ointments, and gels. Its product portfolio combines high-quality chemical generics with traditional Chinese medicine extracts, targeting common conditions such as fungal infections, eczema, and pediatric coughs. The company operates multiple GMP-certified production lines and maintains a comprehensive distribution network across mainland China, supplying both clinical and retail sectors. Dongxin's established presence in the domestic market is supported by its integrated capabilities in drug formulation and large-scale pharmaceutical production.